CUSIP: 37185X106
Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / CL A COM
-
Total 13F shares
-
33,956,494
-
Share change
-
+1,645,669
-
Total reported value
-
$46,550,348
-
Price per share
-
$1.35
-
Number of holders
-
75
-
Value change
-
+$1,342,405
-
Number of buys
-
36
-
Number of sells
-
35
Quarterly Holders Quick Answers
What is CUSIP 37185X106?
CUSIP 37185X106 identifies GENN - GENESIS HEALTHCARE INC - CL A COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2018
-
Previous quarter:
Q2 2018
Recent filing periods for CUSIP 37185X106:
Institutional Holders of GENESIS HEALTHCARE INC - CL A COM (GENN) as of Q3 2018
As of 30 Sep 2018,
GENESIS HEALTHCARE INC - CL A COM (GENN) was held by
75 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,956,494 shares.
The largest 10 holders included
V3 Capital Management, L.P., First Washington CORP, BlackRock Inc., Columbia Pacific Advisors, LLC, RENAISSANCE TECHNOLOGIES LLC, HighTower Advisors, LLC, Vanguard Group Inc, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, and BRIDGEWAY CAPITAL MANAGEMENT INC.
This page lists
75
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.